In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties

Cannabigerol (CBG) is a minor non-psychoactive cannabinoid present in Cannabis sativa L. (C. sativa) at low levels (<1% per dry weight) that serves as the direct precursor to both cannabidiol (CBD) and tetrahydrocannabinol (THC). Consequently, efforts to extract and purify CBG from C. sativa is b...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Eduardo, Fernandez, Jose R., Fitzgerald, Corey, Rouzard, Karl, Tamura, Masanori, Savile, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778347/
https://www.ncbi.nlm.nih.gov/pubmed/35056807
http://dx.doi.org/10.3390/molecules27020491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778347/
https://www.ncbi.nlm.nih.gov/pubmed/35056807
http://dx.doi.org/10.3390/molecules27020491

Ejemplares similares